Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial-Reference-Cited by-同舟云学术

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Published:2021-07 Issue:10297 Volume:398 Page:303-313
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chen Yu-Pei,Liu Xu,Zhou Qin,Yang Kun-Yu,Jin Feng,Zhu Xiao-Dong,Shi Mei,Hu Guo-Qing,Hu Wei-Han,Sun Yan,Wu Hong-Fen,Wu Hui,Lin Qin,Wang Hui,Tian Ye,Zhang Ning,Wang Xi-Cheng,Shen Liang-Fang,Liu Zheng-Zheng,Huang Jing,Luo Xiu-Ling,Li Ling,Zang Jian,Mei Qi,Zheng Bao-Min,Yue Dan,Xu Jing,Wu San-Gang,Shi Yan-Xia,Mao Yan-Ping,Chen Lei,Li Wen-Fei,Zhou Guan-Qun,Sun Rui,Guo Rui,Zhang Yuan,Xu Cheng,Lv Jia-Wei,Guo Ying,Feng Hui-Xia,Tang Ling-Long,Xie Fang-Yun,Sun Ying,Ma Jun

Funder

National Natural Science Foundation of China

Guangdong Provincial Natural Science Foundation

Publisher

Elsevier BV

Subject

General Medicine

Reference45 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Nasopharyngeal carcinoma;Chen;Lancet,2019

3. Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline;Chen;J Clin Oncol,2021

4. Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials;Chen;Clin Cancer Res,2018

5. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma;Hui;J Clin Oncol,2009

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial;Nature Communications;2024-02-03

2. Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-02

3. Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial;Nature Communications;2024-01-31

4. Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders;Cancers;2024-01-16

5. The E3 ligase NEURL3 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma by promoting vimentin degradation;Journal of Experimental & Clinical Cancer Research;2024-01-09